Researchers identify over 140 genes linked to immune system regulation
First extensive immune profiling of mice reveals a vast catalogue of genes that regulate the immune system and model human disease
Scientists from the Wellcome Sanger Institute and King’s College London have led a major multicentre analysis of over 500 genetically modified mouse lines to explore the effect of disrupting single genes on the immune system.
The immune system is increasingly implicated in many functions of the body beyond infection, with involvement documented in cancer, obesity, and neurodegeneration. However, there is only a very limited understanding of the genes and pathways that regulate the immune system.
Published today (16th December) in Nature Immunology, researchers developed a set of systematic and high-throughput tests for mouse strains to reproducibly and comprehensively identify roles for individual genes in the immune system.
The researchers created and analysed 530 genetic variant mouse lines in the study. They found more than 140 genes involved in controlling the number or activity of immune cells, or the response to infection by pathogens including salmonella and the flu. Many of these genes had not been associated with the immune system before. The screen also swiftly picked up the genes Arpc1b, Cog6, and Bach2, which have since been found to be altered in patients with immune system disorders.
“In this study we made no assumptions a priori about the relevance of the genes we analysed to immunology. This permitted us to uncover 80 new genes with immune regulatory functions, that had never previously been implicated in immunology.”
Professor Adrian Hayday Co-senior author, from the School of Immunology & Microbial Sciences, Kings College London
“Our study is helping us to understand the immune system. We were delighted to find several genes that impact the immune system which have now also been associated with immune disorders in humans.”
Dr David Adams Co-senior author from the Wellcome Sanger Institute
The next steps in this research are to investigate the pathways by which the identified genes regulate the immune system, and to investigate the potential of these as diagnostics or therapeutics in the clinic.
“The datasets we have generated serve as a resource that can be mined for years to come. In vivo models are critically important for validating the link between human genetics and disease genes and for the generation of new treatments.”
Dr Adam Laing School of Immunology & Microbial Sciences, Kings College London
All of the data can be viewed on 3i Consortium website.
L. Abeler-Dörner, A.G. Laing, A. Lorenc et al. (2019) High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variation. Nature Immunology. DOI: 10.1038/s41590-019-0549-0
The 3i consortium was funded by Wellcome and included investigators from the Universities of Oxford, Cambridge and Manchester, Imperial College London, and the Francis Crick institute. Please see the paper for their full funding information.
King’s College London is one of the top 10 UK universities in the world (QS World University Rankings, 2018/19) and among the oldest in England. King’s has more than 31,000 students (including more than 12,800 postgraduates) from some 150 countries worldwide, and some 8,500 staff. King’s has an outstanding reputation for world-class teaching and cutting-edge research. In the 2014 Research Excellence Framework (REF), eighty-four per cent of research at King’s was deemed ‘world-leading’ or ‘internationally excellent’ (3* and 4*). Since our foundation, King’s students and staff have dedicated themselves in the service of society. King’s will continue to focus on world-leading education, research and service, and will have an increasingly proactive role to play in a more interconnected, complex world. Visit our website to find out more about Vision 2029, King’s strategic vision for the next 12 years to 2029, which will be the 200th anniversary of the founding of the university. World-changing ideas. Life-changing impact: https://www.kcl.ac.uk/news/headlines.aspx
The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.
Related blog posts
Why use the mouse in research?
Humans and mice share many common genetic features and by examining the physiology, anatomy and metabolism of a mouse, scientists can ...
11 May 2021
Identifying the rise of multi-drug resistant E.coli
Largest genomic study of E.coli has tracked the rise of multi-drug resistance (MDR) in Norway.
30 Apr 2021
New genetic target for blood cancer treatment
Researchers have identified a vulnerability in some cases of acute myeloid leukaemia that could be harnessed for targeted treatment of these ...